The Online Investor
Biotechnology M&A image Biotechnology M&A » By The Online Investor Staff, updated Sat., Aug. 13, 12:01 PM Recent mergers and acquisitions in the Biotechnology M&A category.

Slide #40. StemCells, Inc. Seminal Neural Stem Cell Patent Portfolio

Acquirer: StemCells, Inc. (NYSE:STEM)
Acquiree: Seminal Neural Stem Cell Patent Portfolio
Details: StemCells, Inc. (Nasdaq:STEM) today announced the acquisition of a portfolio of issued US and Canadian patents to which it had previously held an exclusive worldwide license. The portfolio broadly claims the manufacture and proliferation of purified populations of human neural stem cells and their use as therapeutics and as tools for drug discovery. The acquisition relieves the Company of all milestone and royalty obligations under the license agreements for products claimed by the patents, such as products derived from the Company's proprietary HuCNS-SC cells (purified human neural stem cells). The patents arose from the groundbreaking research of Samuel Weiss, Ph.D., and Brent Reynolds, Ph.D., while at the University of Calgary. As consideration for the portfolio, the Company will issue 139,548 shares of common stock to Neurospheres Holdings Ltd., an intellectual property holding company affiliated with the University of Calgary.

Stem is a newly formed blank check company established for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Co.'s focus is on identifying opportunities in several trends of potential interest including renewable energy generation, bio fuels, carbon capture, hydrogen technologies, fuel cells, electric vehicle infrastructure, transportation, mobility, energy transportation and storage and other Energy Transition technologies.

STEM SEC Filing Email Alerts Service


Open the STEM Page at The Online Investor »

Company Name: 
Stem Inc
Website: 
www.stem.com
Sector: 
Uncategorized
Number of ETFs Holding STEM: 
36
Total Market Value Held by ETFs: 
$305.19M
Total Market Capitalization: 
$2.31B
% of Market Cap. Held by ETFs: 
13.18%
 

Open the STEM Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree STEM Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.00 out of 4)
17th percentile
(ranked lower than approx. 83% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Biotechnology M&A - Slide 40 of 83 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.